Technology · Forestry & biomaterials / Fibers & textiles

Recombinant collagen for cosmetics

Precision-fermentation collagen engineered specifically for skincare and injectable aesthetic medicine — matching the human collagen sequence, free of prion and allergenicity risk, and small enough to penetrate skin's epidermal barrier — powering China's dominant recombinant-collagen skincare industry and premium Western dermal-filler and cosmetic-ingredient lines.

Risk: medium Cosmetics US · EU · CN Science: why it works → verified 2026-07-05 · 5 Sources (0 independent)

1 · What it gives

Recombinant collagen for cosmetics is engineered specifically for topical skincare and injectable aesthetic medicine, produced via precision fermentation in Pichia pastoris yeast or E. coli engineered to co-express human prolyl-4-hydroxylase (P4H) alongside collagen genes, yielding a protein with full human sequence identity, no prion or viral contamination risk, and — critically for cosmetic penetration — controllable low molecular weight (5-10 kDa mini-collagen fragments) able to cross the epidermal barrier that intact 300+ kDa animal collagen cannot. Giant Biogene, based in Xi’an and founded in 2000 by chief scientist Prof. Fan Daidi (who began collagen biomaterials research in 1994), is the world’s largest recombinant collagen producer; its Collgene and Comfy (可复美) skincare brands built on “Human-like Collagen” generate hundreds of millions of dollars in annual revenue. Jinbo Bio-pharmaceutical (listed on the Beijing Stock Exchange, ticker 832982.BJ), the leader in injectable recombinant collagen through its Weiyimei (薇旖美) brand of recombinant Type III humanized collagen, reported H1 2025 revenue of RMB 859 million (+42.43% year-on-year) and net profit of RMB 392 million (+26.65%), with over 2.7 million units of its collagen medical device used clinically — though growth decelerated sharply from the 90-180% rates seen in 2023-2024, a signal the sector’s earlier hypergrowth phase is maturing. In the US, Geltor introduced HumaColl21 Select in March 2026, a Type XXI collagen-based “matrikine” complex using precision proteolysis to concentrate biomimetic signaling peptides for topical skin health, building on its earlier HumaColl21 and Collume cosmetic ingredients. Germany’s Evonik launched VECOLLAN, a fermentation-based recombinant collagen mimicking the natural triple-helix structure, first as a vegan cosmetic ingredient in February 2024 and then in a clinical-grade version for clinical trials and medical device development in September 2025. BASF, partnering with Bota Biosciences, launched SkinNexus Collag3n in June 2026 — a 100% human-identical recombinant Collagen III fragment for the personal care market, alongside its NeoHelix Regenerate adaptive collagen rejuvenation ingredient, both debuted at in-cosmetics Global in April 2026.

The key directions of recombinant collagen for cosmetics are:

Topical skincare collagen: low-molecular-weight recombinant collagen fragments engineered to penetrate the epidermal barrier and stimulate fibroblast activity, unlike surface-sitting animal collagen.
Injectable aesthetic collagen: full triple-helix recombinant human collagen (typically Type III) manufactured to medical-device purity for dermal fillers and wrinkle-correction injections.
Matrikine and signaling-peptide technology: precision proteolysis of collagen fragments to concentrate specific biomimetic peptides that signal skin cells to synthesize their own neocollagen.
Vegan and cruelty-free certification: full elimination of animal-derived material, meeting Millennial and Gen Z consumer demand for cruelty-free, vegan-certified beauty ingredients.

Sectoral value chain#

[Genetic design of collagen genes] ──> [Precision fermentation (yeast/E. coli)] ──> [Chromatographic protein purification]
                                                                                                        │
                                                                                           (Conditioning & stabilization)
                                                                                                        │
               [Premium cosmetic cream/filler] <─── [Formulation into emulsion recipes] <─── [LIMS purity & structure control]

Value chain levels#

Level	Description	Key inputs/outputs
Genetic design	Constructing plasmids carrying human collagen (Type I/III) genes with co-expressed P4H.	In: Synthetic genes, expression vectors, restriction enzymes. Out: Stable producer strains (P. pastoris/E. coli).
Industrial upstream fermentation	Culturing engineered strains in high-pressure fermenters with controlled methanol/glucose feed.	In: Producer strains, growth media, fermenters (10,000-100,000 L). Out: Culture broth rich in target protein.
Primary separation	Disrupting cells (E. coli) or separating cell mass by centrifugation (secreting yeast).	In: Culture medium, cell disruptors, decanter centrifuges. Out: Crude collagen protein extract.
Chromatography purification	Multi-stage column chromatography (ion-exchange and hydrophobic) for ultra-high protein purity.	In: Crude extract, chromatography columns, buffer solutions. Out: Purified recombinant collagen solution (>98% purity).
Structure and stabilization	Freeze-drying purified protein into white powder or stabilizing as aqueous solution with preservatives.	In: Pure protein, lyophilizers, stabilizers (glycerin). Out: Commercial-grade cosmetic recombinant collagen.
Cosmetic formulation	Incorporating recombinant protein into rejuvenating serums, creams and masks, with LIMS quality audit.	In: Collagen raw material, cosmetic bases, emulsion mixers, LIMS. Out: Finished premium “cellular” anti-aging cosmetics.

Cross-cutting technologies of the sector:

P4H co-expression for triple-helix stability: integrating human P4H genes into the host alongside collagen genes drives intracellular prolyl-hydroxylation, letting synthesized peptide chains spontaneously fold into a thermostable triple helix resistant to enzymatic breakdown at skin temperature (37°C).
Ion-exchange and hydrophobic chromatography: a cascade of cation-exchange resin (binding collagen at low pH, eluting with a salt gradient) followed by hydrophobic-interaction chromatography removes bacterial pyrogens and impurity proteins, achieving over 98.5% purity with endotoxin levels below 0.1 EU/mg.
Matrikine signaling-peptide concentration: precision proteolysis breaks collagen into specific biomimetic fragments recognized by integrin receptors (alpha2beta1) on fibroblasts, triggering an intracellular signaling cascade that drives the skin’s own neocollagen synthesis.

2 · What it replaces 3 · matched by industry

D1E–	Fermentation cosmetic ingredients instead of shark-liver squalene, rooster-comb hyaluronic acid and animal collagen Replaces: Shark-liver oil squalene (deep-sea shark fisheries); hyaluronic acid from rooster combs; bovine/porcine collagen extracts (and their …	COSM
D3E2	Biodegradable scrub particles and exfoliants instead of polyethylene microbeads Replaces: Polyethylene (and PP/PET/PMMA) microbeads in rinse-off cosmetics: face/body scrubs, toothpastes, shower gels; glitter (polyester/alu …	COSM
D1E–	Biosurfactant and APG cleansing — sophorolipids, rhamnolipids, alkyl polyglucosides — instead of petrochemical SLES/SLS Replaces: Petrochemical anionic surfactants (SLES/SLS) and their ethoxylated feedstock chain (1,4-dioxane contamination risk at trace levels, …	COSM

3 · How to implement 6 steps

1
P. pastoris strain inoculation with P4H geneStrains & cell lines
A 1 m³ seed bioreactor is loaded with sterile YPD growth medium and inoculated with a recombinant Pichia pastoris strain carrying synthetic genes for the human Type III collagen alpha-1 chain and co-expressed P4H, cultivated for 24 hours to reach stationary-phase biomass.
Who can do this step matched automatically
Bloomage Biotechnology China
✓ GMP 320 tons industrial scale
“[About Bloomage Biotech - 华熙生物 — Bloomage Biotech is a leading biotechnology and biomanufacturing company founded in 2000, focused on innovative synthetic biology with an …”
Esco Aster Singapore
✓ ISO 9001 5,000 L industrial scale
“Platform and capabilities: end-to-end support from discovery to market approvals, with services spanning cell line creation, GMP/MO handling, CMC/PD/AD, MSAT …”
PhaBuilder 微构工场 China
✓ GMP 30,000 tons/year industrial scale
“Ultimately, it aims to realize the beautiful vision of “making PHA Life a lifestyle for thousands of households” and to implement the synthetic biology innovation path of …”
CHITOSE Japan
industrial scale
“STABLE CELL LINE DEVELOPMENT SERVICE”
2
High-density industrial fermentation with methanol inductionFermentation & cultivation
Seed material is transferred to a 100 m³ industrial fermenter; the initial phase runs on glucose for rapid cell-density buildup, then automatic methanol feed (activating the AOX1 promoter) begins once glucose depletes, with fermentation continuing for 96 hours at 28±0.2°C under 0.2 MPa pressure with pure oxygen supply, as the yeast secretes the synthesized triple-helical collagen directly into the culture medium.
Who can do this step matched automatically
Cell AgriTech Malaysia
5,000 L industrial scale
“We design and fabricate our own stainless-steel bioreactors, automation systems, and harvesting modules, which lower CAPEX and OPEX by more than 80% compared to pharma-grade …”
TurtleTree Singapore
industrial scale
“At TurtleTree, we are pioneering the future of health with our breakthrough product, LF+: the world’s first vegan lactoferrin created through cutting-edge precision fermentation …”
Loopworm India
✓ GMP 6,000 tonnes/year industrial scale
“At Loopworm, we are building the future of sustainable biomanufacturing.”
Bloomage Biotechnology China
✓ GMP 320 tons industrial scale
“Bloomage Biotechnology Corporation Limited (Bloomage Biotech, SSE STAR: 688363) is a China-based biotech/biomanufacturing company using fermentation and cross-link technologies to …”
Ajinomoto Japan
✓ GMP industrial scale
“It specializes in amino acid fermentation technology, applying it to seasonings, processed foods, frozen foods, and healthcare solutions.”
Esco Aster Singapore
✓ ISO 9001 5,000 L industrial scale
“TideMotion® Bioreactors”
3
Centrifugation and TFF ultrafiltrationPurification & downstream
The culture broth passes through a high-speed tangential decanter centrifuge to remove yeast cells as sludge, with the clarified centrate containing the target protein directed to a tangential-flow-filtration (TFF) system with a 50 kDa membrane cutoff for 20x concentration and simultaneous diafiltration against sodium phosphate buffer (pH 6.5).
Who can do this step matched automatically
Tsukishima Kikai Japan
✓ ISO 9001
“Crystallization and refining: In-house developed DP Crystallizer and Oslo Crystallizer for tailored crystallization and refining processes; integrated purification units combining …”
Esco Aster Singapore
✓ ISO 9001 5,000 L industrial scale
“Adherent cell culture and downstream processing: commercialized Tide Motion bioreactor platform (MiniTide to TideXcell) with closed automated cell harvesting and single-use …”
Algalif Iceland
✓ GMP
“• HACCP principles are employed in our downstream processing”
Advanced Enzyme Technologies (NSE) India
✓ GMP ✓ ISO 9001 500 m3
“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”
4
Multi-stage IEX/HIC chromatography purificationPurification & downstream
The concentrated protein solution passes through a cation-exchange resin column (SP Sepharose Fast Flow) at low pH, binding collagen while yeast impurity proteins wash out, then elutes via salt gradient onto a second hydrophobic-interaction column (Phenyl Sepharose) for final purification and deep pyrogen removal, yielding protein purity above 99%.
Who can do this step matched automatically
Tsukishima Kikai Japan
✓ ISO 9001
“Crystallization and refining: In-house developed DP Crystallizer and Oslo Crystallizer for tailored crystallization and refining processes; integrated purification units combining …”
Esco Aster Singapore
✓ ISO 9001 5,000 L industrial scale
“Adherent cell culture and downstream processing: commercialized Tide Motion bioreactor platform (MiniTide to TideXcell) with closed automated cell harvesting and single-use …”
Algalif Iceland
✓ GMP
“• HACCP principles are employed in our downstream processing”
Advanced Enzyme Technologies (NSE) India
✓ GMP ✓ ISO 9001 500 m3
“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”
5
Freeze-dryingPurification & downstream
The purified collagen solution is sterile-filtered through a 0.22 μm membrane, frozen in trays at -45°C, then freeze-dried over 36 hours under deep vacuum with gradually rising temperature to +25°C, yielding a light, white, sponge-like powder of recombinant Type III collagen.
Who can do this step matched automatically
Tsukishima Kikai Japan
✓ ISO 9001
“Crystallization and refining: In-house developed DP Crystallizer and Oslo Crystallizer for tailored crystallization and refining processes; integrated purification units combining …”
Esco Aster Singapore
✓ ISO 9001 5,000 L industrial scale
“Adherent cell culture and downstream processing: commercialized Tide Motion bioreactor platform (MiniTide to TideXcell) with closed automated cell harvesting and single-use …”
Algalif Iceland
✓ GMP
“• HACCP principles are employed in our downstream processing”
Advanced Enzyme Technologies (NSE) India
✓ GMP ✓ ISO 9001 500 m3
“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”
6
Circular dichroism and LIMS quality certificationData, software & automation
A 5 g sample is taken from each 50 kg batch for quality control; circular dichroism spectroscopy across 190-260 nm confirms proper triple-helix folding (a characteristic positive peak at 220 nm and negative peak at 197 nm), SDS-PAGE electrophoresis confirms molecular weight (120 kDa) and purity, and results are logged into the LIMS system, which generates an electronic quality certificate under ISO 22716 (cosmetic GMP) standards before shipment to premium cosmetic brand manufacturers.
Who can do this step matched automatically
China Everbright Environment Group China
163,050 tonnes
“As the fundamental component of 5G deployment, optic fibre is critical to making Hong Kong a smart city and laying the groundwork for IoT.”
PBS Biotech United States
✓ GMP ✓ ISO 9001 industrial scale
“PBS-3 Vertical-Wheel Bioreactor Software 3.0 (21 CFR Part 11 cGMP Upgrade)”
Bota Bio 恩和生物 China
✓ ISO 9001 600 tons pilot scale
“Recent 2025-2026 developments include the launch of the SAION AI platform, a strategic partnership with Proya Cosmetics, and the 2026 market introduction of bio-identical Collagen …”
India Glycols (NSE) India
✓ GMP ✓ ISO 9001 7,500 MT/ industrial scale
“Even the administrative processes are green, where IGL has adopted the latest SAP ERP (S/4 HANA 2023 version), Salesforce CRM, Industrial IOT & other tech solutions to drive …”

4 · Who delivers

Matched suppliers (matched automatically)

Jiangsu Trautec	China	Producer	active
Giant Biogene Holding	China	Distributor	active
Jiangsu Jland Biotech	China	Producer	active
TurtleTree	Singapore	Producer	active
Modern Meadow	United States	Producer	active

In the services and supply catalogue 2 · paid service

Biopolymers & materials · Contract manufacturing (CMO/CDMO/toll)

Leading companies and institutes (from the brief)

Company / Institute	Country	Key products / platforms	Tech features	Status 2026
Giant Biogene	🇨🇳 China	Collgene, Comfy (可复美) “Human-like Collagen”	High-yield E. coli expression, global production leader	commercial
Jinbo Bio-pharmaceutical	🇨🇳 China	Weiyimei injectable Type III collagen	Full triple-helix assembly, medical-device grade	commercial
Geltor	🇺🇸 USA	HumaColl21 Select, Collume	Matrikine signaling-peptide concentration (2026)	commercial
Evonik	🇩🇪 Germany	VECOLLAN recombinant collagen	Clinical-grade version launched Sept. 2025	commercial
BASF	🇩🇪 Germany	SkinNexus Collag3n, NeoHelix Regenerate	100% human-identical Collagen III fragment (June 2026)	commercial

5 · Rules & route to market

Route into Russia / EAEU: COSM · EAEU conformity bodies (Rospotrebnadzor for SGR)
declaration (SGR for some categories)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)

United States

The United States hosts pioneering biodesign companies that hold foundational patents in recombinant cosmetic collagen and continue introducing new signaling-peptide technology.

Geltor’s HumaColl21 Select matrikine launch, foundational cosmetic-collagen patents, INCI registration via PCPC#

Geltor: introduced HumaColl21 Select in March 2026, a Type XXI collagen-based matrikine complex using precision proteolysis to concentrate biomimetic signaling peptides for topical skin health, building on its earlier HumaColl21 (the first 100% human Type XXI collagen for cosmetics) and Collume vegan collagen.
INCI registration: the US Personal Care Products Council (PCPC) coordinates assignment of unique INCI codes for new recombinant collagen types (such as sh-Polypeptide-121), a mandatory step before commercial cosmetic launch.
Patent leadership: Geltor holds foundational US patents in biodesigned cosmetic protein technology, positioning it as the reference point other recombinant-collagen cosmetic developers build against.

European Union

The European Union’s strict animal-testing ban drives demand for recombinant collagen validated through in silico and 3D-epidermis testing rather than live-animal trials, with major chemical groups now launching flagship products.

Evonik’s VECOLLAN clinical-grade launch, BASF-Bota Biosciences’ SkinNexus Collag3n, EU animal-testing ban as market driver#

Evonik: launched VECOLLAN, a fermentation-based recombinant collagen mimicking the natural triple-helix structure, first as a vegan cosmetic ingredient in February 2024 and then in a clinical-grade version for clinical trials and medical device development in September 2025.
BASF and Bota Biosciences: launched SkinNexus Collag3n in June 2026, a 100% human-identical recombinant Collagen III fragment for personal care, alongside the NeoHelix Regenerate adaptive collagen rejuvenation ingredient, both debuted at in-cosmetics Global in April 2026.
Animal-testing ban as driver: EU Cosmetics Regulation (EC 1223/2009) fully bans animal-tested cosmetics sale, making recombinant proteins validated via in silico modeling and 3D-epidermis testing the natural choice for European brands seeking cruelty-free, scientifically substantiated anti-aging actives.

China

China is the undisputed global leader in recombinant collagen manufacturing scale, clinical adoption and commercialization, anchored in Xi’an’s “collagen valley” cluster, though 2025-2026 data shows the sector’s hypergrowth phase decelerating.

Giant Biogene’s global production leadership, Jinbo Bio-pharmaceutical’s injectable dominance and growth deceleration, Shaanxi’s national collagen hub#

Giant Biogene: based in Xi’an and founded in 2000 by chief scientist Prof. Fan Daidi, is the world’s largest recombinant collagen producer using high-yield E. coli expression; its Collgene and Comfy skincare brands built on “Human-like Collagen” generate hundreds of millions of dollars in annual revenue.
Jinbo Bio-pharmaceutical: the leader in injectable recombinant collagen through its Weiyimei brand of recombinant Type III humanized collagen, reported H1 2025 revenue of RMB 859 million (+42.43% year-on-year) with over 2.7 million units used clinically, though growth decelerated sharply from the 90-180% rates seen in 2023-2024, signaling the sector’s earlier hypergrowth is maturing into a more normalized expansion phase.
National hub status: recombinant collagen synthesis is listed among China’s national development priorities, with Shaanxi province established as a global hub (“collagen valley”) for recombinant protein manufacturing.

6 · Money: tenders & grants

Grant	Advancing bio-printing of living cells for regenerative medicine European Commission · EU	Sep 22, 2027 341 days
Grant	Continuing Human Enabling Enhancing Restoring and Sustaining Air Force -- Research Lab · United States	Aug 22, 2044 6520 days
Grant	First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based … National Institutes of Health · United States	Oct 15, 2027 364 days
Grant	Health of ecosystems and wild species, predictions and impacts on human health, in the face of existing and … European Commission · EU	Sep 22, 2027 341 days
Grant	Powering Affordable Reliable Technology (PART) Energy Program Rural Utilities Service · United States	rolling

7 · Tech stack & innovations

The recombinant cosmetic collagen stack pairs precise genetic engineering with pharmaceutical-grade purification and signaling-peptide science:

Genetic engineering and P4H co-expression for triple-helix assembly:
- Natural collagen’s triple-helix stability comes from prolyl-4-hydroxylase (P4H)-mediated hydroxylation of proline residues in Gly-Pro-Hyp peptide repeats; since E. coli and yeast lack this enzyme in the needed configuration, human P4H subunit genes are co-transfected alongside collagen genes, letting synthesized chains spontaneously fold into a thermostable triple helix resistant to enzymatic breakdown at 37°C skin temperature.
Downstream purification and pyrogen removal:
- Culture medium (especially from E. coli) contains dangerous bacterial pyrogens (lipopolysaccharides) that trigger inflammatory skin reactions; a chromatography cascade — ion-exchange resin, hydrophobic-interaction chromatography, then 30 kDa-cutoff ultrafiltration — achieves protein purity above 98.5% with endotoxin content below 0.1 EU/mg.
In silico efficacy verification:
- Molecular-dynamics computational modeling calculates how well recombinant collagen fragments bind integrin receptors (alpha2beta1) on human fibroblasts, predicting the intracellular signaling cascade that drives the skin’s own neocollagen synthesis before physical testing begins.

Sources 5 · 0 independent · 5 producer sites

Producers' own sites 5

Giant biogene producer checked 2026-07-05 · link not kept
Geltor producer checked 2026-04-24 · link not kept
Evonik producer checked 2026-06-30 · link not kept
Jinbo bio pharmaceutical producer checked 2026-07-05 · link not kept
Basf producer checked 2026-06-30 · link not kept